Researchers publish cell protein findings to determine effectiveness of immunotherapy for colon cancer

Mayo Clinic Comprehensive Cancer Center researchers have identified key findings that can assist clinicians in predicting whether a patient with advanced colorectal cancer will benefit from immunotherapy. The study was published in the journal Clinical Cancer Research and highlights the potential of using spatial analysis of specific proteins as a predictive tool for selecting appropriate candidates for PD-1 blockade immunotherapy in colorectal cancer, ultimately improving treatment outcomes and minimizing unnecessary treatments.